Thiazovivin is a potent ROCK inhibitor. It dramatically improves the survival of hESCs during cell trypsinization manipulation. Thiazovivin in combination with inhibitors of the TGF-β receptor and the MEK pathway improve reprogramming efficiency more than 200-fold.